Global X Genomics & Biotechnology ETF
GNOM
26 hedge funds and large institutions have $59.9M invested in Global X Genomics & Biotechnology ETF in 2020 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 2 closing their positions.
350% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 2
100% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 4
57% more capital invested
Capital invested by funds: $38.1M → $59.9M (+$21.8M)
37% more funds holding
Funds holding: 19 → 26 (+7)
1.81% less ownership
Funds ownership: 15.57% → 13.76% (-1.8%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$2.35M |
| 2 |
Mirae Asset Global Investments
Seoul,
South Korea
|
+$2.1M |
| 3 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$1.61M |
| 4 |
Jane Street
New York
|
+$1.21M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$449K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$273K |
| 2 |
CFGS
Concourse Financial Group Securities
Birmingham,
Alabama
|
-$34.3K |
| 3 |
AA
Advisory Alpha
Holland,
Michigan
|
-$18K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$16.7K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$16.6K |
GNOM Hedge Fund Activity: Q4 2020 in Review
26 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Global X Genomics & Biotechnology ETF (GNOM) for Q4 2020, worth a combined $59.9M — up 57% from $38.1M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new GNOM positions and 2 closed out — a net gain of 7 holders — while 8 added to existing stakes and 4 trimmed.
The largest buyer was UBS Group, adding an estimated $2.35M. The largest seller was Susquehanna International Group, cutting an estimated $273K.
- 26 institutional investors held Global X Genomics & Biotechnology ETF (GNOM) as of Q4 2020, up from 19 in Q3 2020.
- Funds reported $59.9M of Global X Genomics & Biotechnology ETF stock for Q4 2020, up 57% quarter-over-quarter.
- 9 funds opened new Global X Genomics & Biotechnology ETF positions in Q4 2020 and 2 closed out, a net change of +7 holders.
- The largest Global X Genomics & Biotechnology ETF buyer in Q4 2020 was UBS Group, an estimated $2.35M added.
- The largest Global X Genomics & Biotechnology ETF seller in Q4 2020 was Susquehanna International Group, an estimated $273K sold.
Based on aggregated 13F filings for Q4 2020.